A View LCS vs CAC Software
AI Verdict
Choose A View LCS if…
Choose A View LCS if your clinical practice requires a comprehensive AI-powered solution for multi-faceted thoracic CT analysis, including simultaneous lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. This tool is ideal for facilities seeking automated nodule detection, Lung-RADS reporting, and detailed emphysema and CAC scoring to streamline diagnostic workflows across pulmonology, oncology, and cardiology.
View A View LCS →Choose CAC Software if…
Choose Imbio's CAC Software if your primary focus is highly specialized and detailed coronary artery calcification analysis from non-contrast chest CT scans. This software excels at providing precise quantification of calcification, including Agatston scores, arterial age, and lesion mass/volume, with 3D visualizations, making it optimal for cardiologists and radiologists focused on comprehensive cardiovascular risk assessment and seamless integration into existing DICOM viewing workflows.
View CAC Software →When choosing between AVIEW LCS by Coreline Soft and Imbio’s CAC Software, physicians should consider their primary diagnostic focus. AVIEW LCS offers a comprehensive thoracic CT analysis, excelling in lung cancer screening with automated nodule detection, volume quantification, and Lung-RADS scoring. It also provides emphysema quantification and coronary artery calcification (CAC) detection from a single low-dose CT scan, making it ideal for practices focused on multi-faceted thoracic disease diagnosis and screening programs.
Imbio’s CAC Software, on the other hand, specializes in detailed coronary artery calcification analysis. While both tools offer CAC scoring, Imbio’s solution provides more in-depth quantification, including arterial age, calcified lesion mass, and volume, along with 3D visualizations. The key practical difference lies in their breadth versus depth: AVIEW LCS provides a broader thoracic assessment, while Imbio’s CAC Software offers a more specialized and detailed analysis of coronary calcification. Physicians prioritizing a comprehensive lung cancer screening and general thoracic health assessment would likely prefer AVIEW LCS. Conversely, those whose primary need is a highly detailed and specialized assessment of coronary artery calcification for cardiovascular risk stratification would find Imbio’s CAC Software more suitable.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | A View LCS | CAC Software |
|---|---|---|
| Pricing | Contact for quote | Contact for pricing |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Cloud, On-premise, Partner platforms |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
A View LCSAVIEW LCS offers automated comprehensive report generation in multiple formats (PDF, DICOM PDF, SR) and includes CT kernel conversion AI technology, which can enhance input data consistency. While both integrate into existing workflows, Tool A's additional features suggest a slightly more streamlined user experience.
Clinical Value
A View LCSAVIEW LCS provides comprehensive thoracic CT analysis, including lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. In contrast, Imbio's CAC Software focuses solely on coronary artery calcification. Tool A's broader diagnostic capabilities offer significantly more clinical value from a single examination.
Pricing & Value
A View LCSBoth tools require contacting the vendor for pricing, offering no transparency in this dimension. However, AVIEW LCS provides a much broader range of features and comprehensive analysis for multiple thoracic diseases. Assuming comparable pricing models, Tool A delivers greater overall value due to its expanded clinical utility.
Enterprise Readiness
A View LCSBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating strong regulatory and security readiness. Tool A explicitly lists a wider array of deployment options including cloud-based, hybrid, local dedicated hardware, and locally virtualized solutions (VM, Docker), which provides more flexibility for diverse enterprise IT environments.
Innovation
A View LCSWhile both leverage AI for medical imaging analysis, AVIEW LCS stands out with its comprehensive multi-disease analysis from a single CT scan and its 'CT kernel conversion AI technology'. This technology can improve data consistency, and the integrated analysis of lung cancer, emphysema, and CAC represents a significant innovation in workflow efficiency and holistic patient assessment.
Support & Docs
CAC SoftwareImbio's CAC Software provides more explicit and detailed information regarding its support channels, including dedicated phone numbers (U.S. and India), an email address, and specified support hours. While Coreline Soft offers product documentation and catalogs, Imbio's transparent support contact information indicates a more readily accessible support structure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | A View LCS | CAC Software |
|---|---|---|
| Company | Coreline Soft Co. | Imbio |
| Primary Focus | Comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. | Automated image post-processing algorithms to determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). |
| Coronary Artery Calcification (CAC) Analysis | CAC scoring (Agatston, volume, mass), Segmentation of major coronary arteries | Outputs Agatston score, arterial age, calcified lesion mass and volume; Provides 3D visualizations and annotated images; Non-invasive analysis from non-contrast chest CT scans; Deep-learning based analysis |
| Lung Nodule Detection/Analysis | Automated lung nodule detection and classification, Nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting | Not specified |
| Emphysema Analysis | Emphysema analysis and quantification (LAA) | Not specified |
| Report Generation/Output | Automated comprehensive report generation (PDF, DICOM PDF, SR) | Outputs Agatston score, arterial age, calcified lesion mass and volume; Provides 3D visualizations and annotated images; Integrates into existing DICOM viewing workflow |
Videos
Demos, reviews, and walkthroughs featuring A View LCS and CAC Software.